Haoqi Zhang

Haoqi Zhang

Auto-generated profile, based on publicly available information

Haoqi Zhang

Institute of Organic Chemistry, University of Vienna, Währinger Straße 38, 1090, Vienna, Austria

Research Focus & Metrics

Academic Career Length

1Year (2026-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 April 2026 in Chemical Science
Verified
Journal Article
Open access
PDF file
ISIakovos Saridakis
Iakovos Saridakis
MSManuel Schupp
Manuel Schupp
HZHaoqi Zhang
Haoqi Zhang
TLThomas Leischner
Thomas Leischner
LGLaura Marie Gail
Laura Marie Gail
NMNuno Maulide
Nuno Maulide
The macrocyclic immunosuppressive natural product (−)-FR252921 was isolated in 2003 from a liquid culture of Pseudomonas fluorescens. Despite promising preliminary immunological insights, in-depth studies that advance our understanding of structure–activity relationship (SAR) have been scarce. Herein we document a detailed SAR mapping of (−)-FR252921 by the syntheses of 14 analogs and their subsequent evaluation. The composed library of analogs was designed to address crucial questions regarding the roles of explicit molecular features of the natural product while following a target-agnostic efficacy approach. Whereas previous efforts have focused on murine T cell assays, our endeavors transit to a primary human cell-based immunological platform using peripheral blood mononuclear cells (PBMCs), enabling direct assessment of immunosuppressive activity in B, natural killer (NK), and T cells via cytokine suppression. We emphasize that a new fully synthetic (−)-FR252921 analog (fs-FR4) profoundly outperformed the natural product in suppressing the response of both stimulated B cells (21-fold) and NK cells (16-fold) within the context the biological assays used, validating the power of our platform and standing as a lead candidate for further preclinical development. Lastly, we highlight that our studies included significant improvement in the synthetic efficacy of previously reported building blocks and key synthetic steps towards (−)-FR252921 and analogs.